First Cobalt Corp.

0.2

Canada & Ontario Toronto

140 Yonge Street, Suite 201

+1 604 687-7130

firstcobalt.com

Looking to explore investment opportunities with FCC?

Contact FCC >

Looking to explore investment opportunities with FCC?

Contact FCC >

Is this your business?
Customize your listing.

CLAIM THIS LISTING

Is this your business?
Customize your listing.

Company Press Releases

First Cobalt Continues to Show Continuity of Mineralization at Iron Creek

TORONTO, Nov. 19, 2018 /CNW/ - First Cobalt Corp. (TSX-V: FCC; ASX: FCC; OTCQX: FTSSF) (the "Company") is pleased to report that drill results from its Iron Creek Cobalt Project in Idaho, USA extend mineralization at depth and demonstrate additional mineralization between the two known zones as well as in the footwall of the Waite Zone. Highlights Broad widths of high grade mineralization continue to be intercepted in the eastern portion of the current resource area32.3m of 0.31% Co and 0.31% Cu in ICS18-06B21.1m of 0.32% Co and 0.20% Cu in ICS18-05 (true widths)Massive sulphide in...

First Cobalt Begins Testing Material for Refinery Restart

TORONTO, Nov. 8, 2018 /CNW/ - First Cobalt Corp. (TSX-V: FCC; ASX: FCC; OTCQX: FTSSF) (the "Company") is pleased to announce that it has commenced testing cobalt hydroxide material as feedstock for the First Cobalt Refinery. Highlights SGS Canada retained to test suitability of different cobalt feed material using the First Cobalt Refinery's current flowsheet Cobalt hydroxide material to be assessed as a source of feed for the refinery to produce cobalt sulphate or metallic cobalt products for sale into the North American market Discussions are underway with cobalt miners...

NetworkNewsAudio Announces Audio Press Release (APR) on Exciting New Solutions to Tackle Pain

New York, New York--(Newsfile Corp. - February 5, 2018) - NetworkNewsAudio announces the Audio Press Release (APR) titled "Promising New Approaches in Pain Management," featuring PreveCeutical Medical Inc. (OTCQB: PRVCF) (CSE: PREV) (FSE: 18H). To hear the NetworkNewsAudio version, visit LINKTo read the original editorial, visit LINK"Our preliminary work has highlighted that by using our proprietary linker technology we can enhance stability while maintaining, and in some cases enhancing the potency of lead bioactives," explained Dr. Harry Parekh, PreveCeutical's chief research officer and lea...

See All >

Company News

See All >

NEWSLETTER